Key changes in the treatment of multidrug- and rifampicin-resistant tuberculosis in 2018

Abstract

The World Health Organization has issued a new guideline on the treatment of patients infected with multidrug(MDR-TB) and rifampicin-resistant (RR-TB) tuberculosis. There is a fundamental change in the treatment algorithm for patients infected with these forms of tuberculosis.

Keywords

• tuberculosis
• multidrug-resistant tuberculosis
• rifampicin-resistant tuberculosis
• key changes to treatment